Echometrix develops ultrasound-based products that diagnose and measure a patient's musculoskeletal condition at the point of care.
Echometrix was founded to create products that apply the theory of acoustoelasticity (AE) to the advanced evaluation of biological materials. Our first product offering is trademarked EchoSoft. It is ultrasound-based analytical software, which uses AE to provide an advanced, non-invasive, functional evaluation of ligament, tendon and muscle injuries. EchoSoft is now in use across the globe by opinion leading researchers in biomechanics and medical imaging and will be available for general clinical use in late 2012.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 4, 2012 | Grant | $592.63K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |